[Hematopoietic tuberculosis].
D001853:Bone Marrow / Q000473:pathology; D001856:Bone Marrow Examination; D002779:Cholestasis / Q000139:chemically induced; D004890:Erythema / Q000139:chemically induced; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007970:Leukopenia / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000209:etiology; D014395:Peritonitis, Tuberculous / Q000473:pathology; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000209:etiology*; D014376:Tuberculosis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D014386:Tuberculosis, Hepatic / Q000473:pathology; D014394:Tuberculosis, Osteoarticular / Q000473:pathology; D014400:Tuberculosis, Splenic / Q000473:pathology; D014803:Vitamin B Complex / Q000627:therapeutic use
D014803:Vitamin B Complex; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Tuberculose hématopoïétique